DCLK1 is an optimal target as it represents a more specific CSC marker for colorectal, pancreatic, and possibly other cancers such as gastric cancer, esophageal cancer, breast cancer and renal carcinoma. This evidence concerns the gene DCLK1 and renal carcinoma.